AU2002228119A1 - Thermoformable solid pharmaceutical composition for controlled release of ivabradine - Google Patents
Thermoformable solid pharmaceutical composition for controlled release of ivabradineInfo
- Publication number
- AU2002228119A1 AU2002228119A1 AU2002228119A AU2002228119A AU2002228119A1 AU 2002228119 A1 AU2002228119 A1 AU 2002228119A1 AU 2002228119 A AU2002228119 A AU 2002228119A AU 2002228119 A AU2002228119 A AU 2002228119A AU 2002228119 A1 AU2002228119 A1 AU 2002228119A1
- Authority
- AU
- Australia
- Prior art keywords
- ivabradine
- pharmaceutical composition
- controlled release
- solid pharmaceutical
- thermoformable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- ACRHBAYQBXXRTO-OAQYLSRUSA-N Ivabradine Chemical compound C1CC2=CC(OC)=C(OC)C=C2CC(=O)N1CCCN(C)C[C@H]1CC2=C1C=C(OC)C(OC)=C2 ACRHBAYQBXXRTO-OAQYLSRUSA-N 0.000 title 1
- 229960003825 ivabradine Drugs 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 239000007787 solid Substances 0.000 title 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR00/17015 | 2000-12-26 | ||
| FR0017015A FR2818552B1 (en) | 2000-12-26 | 2000-12-26 | SOLID THERMOFORMABLE PHARMACEUTICAL COMPOSITIONS FOR THE CONTROLLED RELEASE OF IVABRADINE |
| PCT/FR2001/004134 WO2002051387A1 (en) | 2000-12-26 | 2001-12-21 | Thermoformable solid pharmaceutical composition for controlled release of ivabradine |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2002228119A1 true AU2002228119A1 (en) | 2003-01-23 |
| AU2002228119B2 AU2002228119B2 (en) | 2006-04-27 |
Family
ID=8858190
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2002228119A Ceased AU2002228119B2 (en) | 2000-12-26 | 2001-12-21 | Thermoformable solid pharmaceutical composition for controlled release of ivabradine |
Country Status (27)
| Country | Link |
|---|---|
| US (1) | US20040028743A1 (en) |
| EP (1) | EP1345594B1 (en) |
| JP (2) | JP2004518665A (en) |
| KR (1) | KR100542472B1 (en) |
| CN (1) | CN1203844C (en) |
| AT (1) | ATE352290T1 (en) |
| AU (1) | AU2002228119B2 (en) |
| BR (1) | BR0116548A (en) |
| CA (1) | CA2432645A1 (en) |
| CY (1) | CY1106390T1 (en) |
| CZ (1) | CZ304587B6 (en) |
| DE (1) | DE60126332T2 (en) |
| DK (1) | DK1345594T3 (en) |
| EA (1) | EA005814B1 (en) |
| ES (1) | ES2280420T3 (en) |
| FR (1) | FR2818552B1 (en) |
| HK (1) | HK1060514A1 (en) |
| HU (1) | HU229410B1 (en) |
| MX (1) | MXPA03005840A (en) |
| NO (1) | NO333776B1 (en) |
| NZ (1) | NZ526406A (en) |
| PL (1) | PL203835B1 (en) |
| PT (1) | PT1345594E (en) |
| SI (1) | SI1345594T1 (en) |
| SK (1) | SK286413B6 (en) |
| WO (1) | WO2002051387A1 (en) |
| ZA (1) | ZA200304441B (en) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2818552B1 (en) * | 2000-12-26 | 2003-02-07 | Servier Lab | SOLID THERMOFORMABLE PHARMACEUTICAL COMPOSITIONS FOR THE CONTROLLED RELEASE OF IVABRADINE |
| FR2834896B1 (en) * | 2002-01-23 | 2004-02-27 | Servier Lab | ORODISPERSIBLE PHARMACEUTICAL COMPOSITION OF IVABRADINE |
| US20060165790A1 (en) * | 2003-06-27 | 2006-07-27 | Malcolm Walden | Multiparticulates |
| TWI357815B (en) * | 2003-06-27 | 2012-02-11 | Euro Celtique Sa | Multiparticulates |
| GB2418854B (en) | 2004-08-31 | 2009-12-23 | Euro Celtique Sa | Multiparticulates |
| FR2882556B1 (en) | 2005-02-28 | 2007-05-04 | Servier Lab | CRYSTALLINE GAMMA D FORM OF IVABRADINE HYDROCHLORIDE, PROCESS FOR PREPARING THE SAME, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME |
| FR2882553B1 (en) | 2005-02-28 | 2007-05-04 | Servier Lab | CRYSTALLINE BETA FORM OF IVABRADINE HYDROCHLORIDE, PROCESS FOR PREPARING THE SAME, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME |
| WO2010128525A2 (en) | 2009-05-04 | 2010-11-11 | Dinesh Shantilal Patel | A formulation of ivabradine for treating the cardiovascular disease |
| CA2800444C (en) * | 2010-06-14 | 2018-03-20 | Ratiopharm Gmbh | Ivabradine-containing pharmaceutical composition |
| CN101897682B (en) * | 2010-07-13 | 2012-02-15 | 石药集团欧意药业有限公司 | Ivabradine preparation or ivabradine medicinal salt solid preparation and preparation method thereof |
| CN102908327B (en) * | 2011-08-05 | 2015-03-11 | 江苏恒瑞医药股份有限公司 | Sustained release preparation for ivabradine or medicinal salt thereof |
| EP3082772A1 (en) * | 2013-12-20 | 2016-10-26 | Synhton B.V. | Pharmaceutical composition comprising amorphous ivabradine |
| EP3025705B8 (en) | 2014-11-25 | 2018-11-28 | Sanofi Ilaç Sanayi ve Ticaret Anonim Sirketi | Stable ivabradine formulations |
| CN104398486B (en) * | 2014-12-08 | 2018-01-12 | 武汉武药科技有限公司 | A kind of hydrochloric acid Ivabradine osmotic pump controlled release tablet and preparation method thereof |
| EP3366282A1 (en) | 2017-02-28 | 2018-08-29 | Sanovel Ilac Sanayi ve Ticaret A.S. | Solid oral pharmaceutical compositions of ivabradine |
| KR20190001340A (en) * | 2017-06-27 | 2019-01-04 | 에리슨제약(주) | Sustained-release pharmaceutical composition comprising ivabradine and process for preparing the same |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2681862B1 (en) * | 1991-09-27 | 1993-11-12 | Adir Cie | NOVELS (BENZOCYCLOALKYL) ALKYLAMINES, THEIR PREPARATION PROCESS, AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM. |
| DE4138513A1 (en) * | 1991-11-23 | 1993-05-27 | Basf Ag | SOLID PHARMACEUTICAL RETARD FORM |
| US5879705A (en) * | 1993-07-27 | 1999-03-09 | Euro-Celtique S.A. | Sustained release compositions of morphine and a method of preparing pharmaceutical compositions |
| US5965161A (en) * | 1994-11-04 | 1999-10-12 | Euro-Celtique, S.A. | Extruded multi-particulates |
| WO1997008950A1 (en) * | 1995-09-07 | 1997-03-13 | Fuisz Technologies, Ltd. | System for rendering substantially non-dissoluble bio-affecting agents bio-available |
| PT998272E (en) * | 1997-08-26 | 2003-09-30 | Aventis Pharma Inc | PHARMACEUTICAL COMPOSITION FOR COMBINATION OF PIPERIDINOALCANOL DECONGESTIONANT |
| US6673367B1 (en) * | 1998-12-17 | 2004-01-06 | Euro-Celtique, S.A. | Controlled/modified release oral methylphenidate formulations |
| DE19901040A1 (en) * | 1999-01-14 | 2000-07-20 | Knoll Ag | Controlled release dosage forms containing active ingredients which are readily soluble in water |
| FR2795326B1 (en) * | 1999-06-28 | 2001-08-31 | Adir | SOLID THERMOFORMABLE PHARMACEUTICAL COMPOSITION WITH CONTROLLED RELEASE |
| UA80393C2 (en) * | 2000-12-07 | 2007-09-25 | Алтана Фарма Аг | Pharmaceutical preparation comprising an pde inhibitor dispersed on a matrix |
| FR2818552B1 (en) * | 2000-12-26 | 2003-02-07 | Servier Lab | SOLID THERMOFORMABLE PHARMACEUTICAL COMPOSITIONS FOR THE CONTROLLED RELEASE OF IVABRADINE |
-
2000
- 2000-12-26 FR FR0017015A patent/FR2818552B1/en not_active Expired - Fee Related
-
2001
- 2001-12-21 SI SI200130697T patent/SI1345594T1/en unknown
- 2001-12-21 AT AT01989654T patent/ATE352290T1/en active
- 2001-12-21 NZ NZ526406A patent/NZ526406A/en not_active IP Right Cessation
- 2001-12-21 SK SK942-2003A patent/SK286413B6/en not_active IP Right Cessation
- 2001-12-21 KR KR1020037008654A patent/KR100542472B1/en not_active IP Right Cessation
- 2001-12-21 EA EA200300667A patent/EA005814B1/en not_active IP Right Cessation
- 2001-12-21 AU AU2002228119A patent/AU2002228119B2/en not_active Ceased
- 2001-12-21 BR BR0116548-8A patent/BR0116548A/en not_active Application Discontinuation
- 2001-12-21 PT PT01989654T patent/PT1345594E/en unknown
- 2001-12-21 ES ES01989654T patent/ES2280420T3/en not_active Expired - Lifetime
- 2001-12-21 CA CA002432645A patent/CA2432645A1/en not_active Withdrawn
- 2001-12-21 DK DK01989654T patent/DK1345594T3/en active
- 2001-12-21 MX MXPA03005840A patent/MXPA03005840A/en active IP Right Grant
- 2001-12-21 CN CNB018213677A patent/CN1203844C/en not_active Expired - Fee Related
- 2001-12-21 DE DE60126332T patent/DE60126332T2/en not_active Expired - Lifetime
- 2001-12-21 HU HU0302522A patent/HU229410B1/en not_active IP Right Cessation
- 2001-12-21 CZ CZ2003-2020A patent/CZ304587B6/en not_active IP Right Cessation
- 2001-12-21 JP JP2002552533A patent/JP2004518665A/en active Pending
- 2001-12-21 EP EP01989654A patent/EP1345594B1/en not_active Expired - Lifetime
- 2001-12-21 US US10/451,903 patent/US20040028743A1/en not_active Abandoned
- 2001-12-21 WO PCT/FR2001/004134 patent/WO2002051387A1/en active IP Right Grant
- 2001-12-21 PL PL361662A patent/PL203835B1/en unknown
-
2003
- 2003-06-06 ZA ZA200304441A patent/ZA200304441B/en unknown
- 2003-06-16 NO NO20032737A patent/NO333776B1/en not_active IP Right Cessation
-
2004
- 2004-05-17 HK HK04103476A patent/HK1060514A1/en not_active IP Right Cessation
-
2007
- 2007-03-16 CY CY20071100370T patent/CY1106390T1/en unknown
-
2009
- 2009-12-25 JP JP2009295406A patent/JP2010100641A/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2002229140A1 (en) | Controlled release pharmaceutical composition | |
| AU2001286677A1 (en) | Controlled release of substances | |
| AU2002248377A1 (en) | A controlled release pharmaceutical composition | |
| AU2002258563A1 (en) | Pharmaceutical formulations for sustained release | |
| HUP0002469A3 (en) | Solid thermoformable controlled-release pharmaceutical composition | |
| AU2002300377A1 (en) | Compositions for controlled release | |
| AU4477001A (en) | Injectable sustained release pharmaceutical composition and processes for preparing the same | |
| AU2003213151A1 (en) | Controlled release solid dosage carbamazepine formulations | |
| AU2002363360A1 (en) | Dual controlled release dosage form | |
| AU2002228119A1 (en) | Thermoformable solid pharmaceutical composition for controlled release of ivabradine | |
| AUPR602501A0 (en) | Sustained release pharmaceutical composition | |
| AU2002337803A1 (en) | Sustained release pharmaceutical compositions | |
| HUP0302522A3 (en) | Thermoformable solid pharmaceutical composition for controlled release of ivabradine | |
| EP1189597A4 (en) | Oil-core compositions for the sustained release of hydrophobic drugs | |
| AU7405000A (en) | Melt granulated composition and modified release dosage form prepared from said composition | |
| AU2002360717A1 (en) | Controlled release dosage form having improved drug release properties | |
| AU4213299A (en) | Controlled release of substances | |
| AU2001227030A1 (en) | Pharmaceutical composition for controlled release of an active ingredient | |
| AU2001232948A1 (en) | Controlled release of drugs | |
| AU2001248336A1 (en) | Controlled release oral solid forms containing mesalazine as active agent | |
| AU2001248772A1 (en) | Sustained release drug compositions | |
| AU2001221695A1 (en) | Solid pharmaceutical compositions for controlled release of active substances | |
| AU6386801A (en) | System for the release of active ingredients | |
| AU2002351388A1 (en) | Methods and compositions for controlled release of drugs | |
| AU5820900A (en) | Capsule for the controlled release of active substances |